29 related articles for article (PubMed ID: 8855799)
1. Establishment and characterization of a new patient-derived anaplastic thyroid cancer cell line (C3948), obtained through fine-needle aspiration cytology.
Pinto AT; Pojo M; Simões-Pereira J; Roque R; Saramago A; Roque L; Martins C; André S; Cabeçadas J; Leite V; Cavaco BM
Endocrine; 2019 Nov; 66(2):288-300. PubMed ID: 31368081
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase A-independent inhibition of proliferation and induction of apoptosis in human thyroid cancer cells by 8-Cl-adenosine.
Robinson-White AJ; Hsiao HP; Leitner WW; Greene E; Bauer A; Krett NL; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2008 Mar; 93(3):1020-9. PubMed ID: 18073299
[TBL] [Abstract][Full Text] [Related]
3. Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines.
Rodrigues RF; Roque L; Krug T; Leite V
Br J Cancer; 2007 Apr; 96(8):1237-45. PubMed ID: 17406368
[TBL] [Abstract][Full Text] [Related]
4. A multimodality therapeutic approach in anaplastic thyroid carcinoma: study on 39 patients.
Busnardo B; Daniele O; Pelizzo MR; Mazzarotto R; Nacamulli D; Devido D; Mian C; Girelli ME
J Endocrinol Invest; 2000 Dec; 23(11):755-61. PubMed ID: 11194710
[TBL] [Abstract][Full Text] [Related]
5. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
[TBL] [Abstract][Full Text] [Related]
6. Multistep carcinogenesis in anaplastic thyroid carcinoma: a case report.
Asakawa H; Kobayashi T
Pathology; 2002 Feb; 34(1):94-7. PubMed ID: 11902457
[TBL] [Abstract][Full Text] [Related]
7. Gal-3 is stimulated by gain-of-function p53 mutations and modulates chemoresistance in anaplastic thyroid carcinomas.
Lavra L; Ulivieri A; Rinaldo C; Dominici R; Volante M; Luciani E; Bartolazzi A; Frasca F; Soddu S; Sciacchitano S
J Pathol; 2009 May; 218(1):66-75. PubMed ID: 19199318
[TBL] [Abstract][Full Text] [Related]
8. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
[TBL] [Abstract][Full Text] [Related]
9. Establishment of anaplastic thyroid carcinoma cell lines useful for analysis of chemosensitivity and carcinogenesis.
Asakawa H; Kobayashi T; Komoike Y; Yanagawa T; Takahashi M; Wakasugi E; Maruyama H; Tamaki Y; Matsuzawa Y; Monden M
J Clin Endocrinol Metab; 1996 Oct; 81(10):3547-52. PubMed ID: 8855799
[TBL] [Abstract][Full Text] [Related]
10. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
11. [Expression of the MDR1 gene in five human cell lines of medullary thyroid cancer and reversion of the resistance to doxorubicine by ciclosporin A and verapamil].
Massart C; Gibassier J; Lucas C; Pourquier P; Robert J
Bull Cancer; 1996 Jan; 83(1):39-45. PubMed ID: 8672855
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
